Business
PURE Bioscience to Present at the Joseph Gunnar “Pioneers 2016” Conference on May 5th
PURE Bioscience to Present at the Joseph Gunnar “Pioneers 2016” Conference on May 5th.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented silver dihydrogen citrate (SDC) \n antimicrobial, announced today the Company will present at the Joseph \n Gunnar “Pioneers 2016” Conference on May 5, 2016 at the Palace Hotel in \n New York City.\n \n \n Hank \n R. Lambert, CEO, will present on Thursday, May 5th at \n 11:00am EDT. Lambert will\n \n \n \n Review progress of the commercialization of SDC as a highly effective \n food safety solution, and\n \n \n Discuss the status of its FDA approved PURE Control® antimicrobial\n\n \n \n Now being commercialized as a fresh produce processing aid, and\n \n \n Status of ongoing USDA in-plant testing as a raw poultry \n processing aid\n \n \n SDC test results demonstrate materially significant reduction in Salmonella \n contamination in poultry – and materially significant reduction in Salmonella, \n Listeria and E. coli contamination in produce.\n \n \n \n \n \n The presentation will be webcast live with slides (and available for \n replay) and can be accessed on the Company's website, http://www.purebio.com/investors/events-presentations/.\n \n \n About Joseph Gunnar & Co., LLC\n \n \n Joseph Gunnar is a full service broker-dealer dedicated to assisting \n investors achieve their financial goals by providing a full array of \n investment products and vehicles to private and corporate clients. We \n pride ourselves on our personalized service not often available at many \n \"bulge bracket\" firms. More information is available at http://josephgunnar.com/.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and commercializing our \n proprietary antimicrobial products primarily in the food safety \n arena -- providing solutions to the health and environmental challenges \n of pathogen and hygienic control. Our technology platform is based on \n patented stabilized ionic silver, and our initial products contain \n silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic \n antimicrobial agent, which offers 24-hour residual protection and \n formulates well with other compounds. As a platform technology, SDC is \n distinguished from existing products in the marketplace because of its \n superior efficacy, reduced toxicity and the inability of bacteria to \n form a resistance to it. PURE i...